|
1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323:2052-59. doi: 10.1001/jama.2020.6775. 2. Vickers NJ. Animal communication: when i’m calling you, will you answer too? Curr Biol 2017;27: R713-R715. doi: 10.1016/j.cub.2017.05.064. 3. Ivanov D, Dolgui A. OR-methods for coping with the ripple effect in supply chains during COVID-19 pandemic: Managerial insights and research implications. Int J Prod Econ 2021; 232:107921. doi: 10.1016/j.ijpe.2020.107921. 4. Bubar KM, Reinholt K, Kissler SM. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. medRxiv [Preprint]. 2020; 7:2020-09. doi: 10.1101/2020.09.08.20190629. 5. Sage WH. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. 2020:1-13. doi: 10.1016/j.rinp.2020.103654. 6. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323:1406-7. doi: 10.1001/jama.2020.2565. 7. Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 2020;583:830-3. doi: 10.1038/s41586-020-2312-y. 8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507-13. doi: 10.1016/S0140-6736(20)30211-7. 9. Hadaya J, Schumm M, Livingston EH. Testing individuals for coronavirus disease 2019 (COVID-19). JAMA 2020; 323:1981. doi: 10.1001/jama.2020.5388. 10. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 73. 11. Maqbool A, Khan S, Haleem A, Khan MI. Investigation of drivers towards adoption of circular economy: A DEMATEL approach. InRecent Ad MechanicEngin 2020; pp. 147-160. Springer, Singapore. doi: 10.1007/978-981-15-1071-7_14. 12. Gabus A, Fontela E. World problems, an invitation to further thought within the framework of DEMATEL. Battelle Geneva Research Center, Geneva, Switzerland. 1972:1-8. 13. Maqbool A, Khan NZ. Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method. Diabetes Metab Syndr 2020; 14:887-92. doi: 10.1016/j.dsx.2020.06.024. 14. AlFattani A, AlMeharish A, Nasim M, AlQahtani K, AlMudraa S. Ten public health strategies to control the Covid-19 pandemic: The Saudi Experience. IJID Reg 2021; 12-19. doi: 10.1016/j.ijregi.2021.09.003. 15. Hezer S, Gelmez E, Özceylan E. Comparative analysis of TOPSIS, VIKOR and COPRAS methods for the COVID-19 Regional Safety Assessment. J Infect Public Health 2021; 14:775-86. doi: 10.1016/j.jiph.2021.03.003. 16. Javanian M, Aghamirzaee Mahalli T, Aqatabar Roudbari J. Presenting A Model and Ranking of Factors Effective on Controlling and Coping with the COVID-19 Pandemic in Babol, Northern Iran. J Babol Univ Med Sci 2021; 23:259-66. doi:10.22088/jbums.23.1.259. 17. Chang WC. Taiwan’s Fight against COVID-19: Constitutionalism, Laws, and the Global Pandemic. Verfassungsblog: On Matters Constitutional. 2020. doi:10.17176/20200321-122752-0. 18. Fang Y, Nie Y, Penny M. Transmission dynamics of the COVID‐19 outbreak and effectiveness of government interventions: A data‐driven analysis. J Med Virol 2020; 92:645-59. doi:10.1002/jmv.25750. 19. Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and sever- ity of COVID-19 in South Korea. Int J Infect Dis 2020; 93:339-44. doi: 10.1016/j.ijid.2020.03.031.
|
